PedvaxHIB (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the PedvaxHIB drug offered from Merck Sharp & Dohme Corp.. This Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) |
| SUBSTANCE NAME: | HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN |
| TYPE: | VACCINE |
| PHARMA CLASS: | Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1989-12-20 |
| END MARKETING DATE: | 0000-00-00 |
PedvaxHIB VACCINE Details:
| Item Description | PedvaxHIB from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7.5(ug/.5mL) |
| START MARKETING DATE: | 1989-12-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-4897_96eff106-f303-4140-b50f-34ebb8ad0fb8 |
| PRODUCT NDC: | 0006-4897 |
| APPLICATION NUMBER: | BLA103237 |
Other HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN Pharmaceutical Manufacturers / Labelers:
